Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Recruiting now
Conditions studied: Allergic Bronchopulmonary Aspergillosis (ABPA)
In brief
This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.
Key facts
- Study ID
- NCT07040332
- Run by
- Qianfoshan Hospital
- People needed
- 140
- Starts
- 2025-05-10
- Expected to finish
- 2029-01-31
- Last updated by the study team
- 2025-07-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.
- Meets the diagnostic criteria for fungal-sensitized asthma.
You may not qualify if…
- Human immunodeficiency virus infection.
- Malignant tumor.
- Blood system disease.
- autoimmune system disease.
- History of pulmonary tuberculosis.
- Patients with a history of smoking or still smoking.
- Invasive pulmonary fungal disease.
- Contraindications electronic bronchoscopy
Where it is running
- Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China — Jinan, Shandong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.